State Street Corporation 13D and 13G filings for Sangamo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 12:18 pm Sale |
2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO |
STATE STREET CORP STT |
2,708,368 1.530% |
-7,080,516 (-72.33%) |
Filing |
| 2023-02-07 1:49 pm Purchase |
2022-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO |
STATE STREET CORP STT |
9,788,884 5.970% |
4,974,258 (+103.32%) |
Filing |